Point72 Asset Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-157,335
| Closed | -$1.6M | – | 1168 |
|
|
2020
Q3 | $1.6M | Buy |
+157,335
| New | +$1.6M | 0.01% | 674 |
|
|
2020
Q2 | – | Sell |
-43,347
| Closed | -$528K | – | 1063 |
|
|
2020
Q1 | $528K | Sell |
43,347
-322,977
| -88% | -$3.93M | ﹤0.01% | 632 |
|
|
2019
Q4 | $5.8M | Buy |
+366,324
| New | +$5.8M | 0.03% | 444 |
|